MiniValuatorMiniValuator
    估值工具
  • 股票估值
  • 定价
  • 内容
MiniValuatorMiniValuator

极简股票估值工具(DCF & PE),源自我们的投资社区。

工具
DCF 计算器PE 计算器工具对比DCF 估值PE 估值定价
热门股票
AAPL 股票估值MSFT 股票估值GOOGL 股票估值AMZN 股票估值TSLA 股票估值查看全部
学习
DCF 方法论PE 方法论术语表使用指南投资洞察
核心概念
内在价值自由现金流WACC安全边际终值市盈率
社区
关于我们小红书Newsletter
资源
llms.txtllms-full.txt
Built for value investors
© 2024 MiniValuator, All rights reserved
隐私政策服务条款
››SYK

Stryker Corporation (SYK) DCF 估值

Medical - Devices · NYSE

当前价格

$336.77

内在价值

使用下方计算器估算

计算 SYK 内在价值

对 Stryker Corporation 运行完整的 DCF 分析,自动填充基本面数据,可调节假设参数,含敏感性热力图。

公司简介

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

财务指标 — SYK 估值数据

ROIC (TTM)

10.1%

ROE (TTM)

15.0%

FCF Yield

3.32%

基于过去 12 个月的数据,SYK 每股自由现金流为 N/A,投入资本回报率(ROIC)为 10.1%,这些是使用 DCF 方法进行股票估值的关键输入。P/FCF 比率为 N/A,FCF 收益率为 3.32%,是评估 SYK 相对估值的重要参考指标。

常见问题

SYK 的内在价值是多少?

SYK 的内在价值取决于对未来增长率、折现率(WACC)和终值的假设。使用 MiniValuator 免费 DCF 计算器,输入你自己的假设进行估算,并查看敏感性分析热力图。

SYK 被低估了吗?

SYK 是否被低估取决于你的 DCF 假设。如果计算出的内在价值显著高于当前市价,则可能被低估。安全边际指示低估程度。在 MiniValuator 上运行完整估值来了解。

如何对 SYK 进行估值?

你可以使用 MiniValuator 的 DCF 计算器对 SYK 估值:输入代码,查看自动填充的基本面数据,调整增长率和折现率假设,即可获得含敏感性热力图的即时内在价值。

什么是 DCF 估值,如何应用于 SYK?

DCF(折现现金流)估值通过将公司未来预期自由现金流折现回现值来估算内在价值。对于 SYK,你输入预期增长率和折现率(WACC),模型会根据其未来现金产生能力计算股票当前应有的价值。

WACC 如何影响 SYK 的估值?

WACC(加权平均资本成本)是 SYK 估值中使用的折现率。较高的 WACC 会降低内在价值估算,较低的 WACC 则会提高。使用 MiniValuator 的敏感性热力图查看不同 WACC 假设对 SYK DCF 估值结果的影响。

了解更多

  • 查看 SYK PE 估值 → — 基于收益的 PE 市盈率估值分析
  • DCF 方法论 — 折现现金流分析分步指南
  • PE 方法论 — PE 市盈率估值指南
  • WACC — 理解 DCF 中使用的折现率
  • 安全边际 — 如何评估下行保护
  • 如何计算内在价值 — 投资者完整指南

相关估值

UNH查看 DCFJNJ查看 DCFLLY查看 DCFABBV查看 DCFMRK查看 DCFTMO查看 DCFABT查看 DCFDHR查看 DCF
DCF 估值
Healthcare
打开 SYK DCF 计算器
或试试 SYK PE 市盈率估值 →